Andrew Huberman· PhD
I think if you really look at the physiology of cancer I don't think it's obesity I think it's two things that come with obesity insulin resistance which is you know 2/3 to 3/4 of obese individuals are insulin resistant and inflammation and I think those two things with the inflammation and the immune dysfunction with the insulin resistance and the hyper basically tonic growth stimulus that's coming that's what's driving cancer